Recently, Jiangsu Provincial Science and technology department has unveiled its first batch of “2020 crucial provincial research and development projects”, Jiangsu MicroDiag’s Human Septi-9 gene methylation test kit (fluorescent PCR) successfully made it on the list, index number 124.
MicroDiag’s Human Septin-9 gene methylation test kit uses 2nd generation methylation technology, methylation specific primer amplification, discarding the 1st generation technology often employed by MicroDiag’s competitors. This technology has drastically reduced the rate of false positives, increased the detection rate of Colorectal cancer, positive matching rate as high as 85% ~ 95%, specificity greater than 95%. This product has gained registration approve by Chinese NMPA in 2018: 20183400103, mainly used in early detection and diagnostics of Colorectal cancer, treatment monitoring and so on.
Coming after this recognition as a crucial project by the Jiangsu Provincial government, we plan on collaborating with experts in the field and national key hospitals to commence a large-scale comparative study against Colonoscopy results, in order to establish the correlation between MicroDiag’s S9 test kit results and colonoscopy results, providing key insights for clinical diagnostics.
For over 10 years, MicroDiag has tirelessly dedicated to the research and development of molecular detection technology and high-quality innovative products, committing to contribute our unique strength for human health.